ClinicalTrials.Veeva

Menu

Factors That Impact the Relationship Between Pulmonary Status and Actual Electronic Cigarette Use

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Completed

Conditions

Electronic Cigarette Use
Pulmonary Disease

Treatments

Other: health-related telephone surveys

Study type

Observational

Funder types

Other

Identifiers

NCT04135404
IRB 300003376

Details and patient eligibility

About

Secondary data analysis will be performed as our approach to complete the study. A nationally representative dataset (BRFSS, 2017) will be used to answer the above hypotheses.

Full description

Secondary data analysis will be performed as our approach to complete the study. A nationally representative dataset (BRFSS, 2017) will be used to answer our research questions. Our rationale is that there is insufficient research assessing the relationship between pulmonary status and e-cigarette use and that some factors, such as behavioral variables or psychosocial variables, might influence this relationship. Our expectation is that this study will deepen the understanding of the relationship between pulmonary status and e-cigarette use among U.S. adults. This study will cast light on different factors that influence the relationship between pulmonary status and e-cigarette use. Also, the following secondary outcomes will be tested: Severity of COPD symptoms (COPD group) moderate the relationship between pulmonary status (COPD status) and e-cigarette use, and Severity of asthma symptoms (asthma group) moderate the relationship between pulmonary status (asthma status) and e-cigarette use.

Enrollment

400,000 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

This is secondary data analysis, so there is no control over the data (inclusion criteria, and exclusion criteria).

Inclusion Criteria:

Group 1: Pulmonary

  • Are 18 years of age or older.
  • Reported any of the pulmonary disease (Asthma, COPD). Group 2: Control Group
  • Are 18 years of age or older.
  • Free from any pulmonary disease (asthma, COPD).

Exclusion Criteria Group 1: Pulmonary

  • Are younger than 18 years of age.
  • Did not report any of the pulmonary disease (Asthma, COPD). Group 2: Control Group
  • Are younger than 18 years of age.
  • Reported any pulmonary disease (asthma, COPD

The Behavioral Risk Factor Surveillance System (BRFSS) is health-related telephone surveys that collect state data about United States residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services. This database contains data to help determine e-cigarette use in individuals with pulmonary disease in the US which little is known.

Note: The Behavioral Risk Factor Surveillance System (BRFSS) is a public dataset, and the data is publicly available online at (https://www.cdc.gov/brfss/annual_data/annual_2017.html)

Trial design

400,000 participants in 2 patient groups

Pulmonary Group
Description:
This project will be achieved by using a publicly available data set (Behavioral Risk Factor Surveillance System, 2017). The subjects from the data set will be selected on their pulmonary status; pulmonary group are those who have reported any pulmonary diseases and they will be included in this study as pulmonary group.
Treatment:
Other: health-related telephone surveys
Control Group
Description:
This project will be achieved by using a publicly available data set (Behavioral Risk Factor Surveillance System, 2017). The subjects from the data set will be selected on their pulmonary status; The control group are subjects without pulmonary diseases and they will be included as (control group).
Treatment:
Other: health-related telephone surveys

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems